Literature DB >> 21978848

The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis.

X N Huang1, J Fu, W Z Wang.   

Abstract

Dysfunction of the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) is a primary characteristic of multiple sclerosis (MS). We evaluated the protective effects of fasudil, a selective ROCK inhibitor, in a model of experimental autoimmune encephalomyelitis (EAE) that was induced by guinea-pig spinal cord. In addition, we studied the effects of fasudil on BBB and BSCB permeability. We found that fasudil partly alleviated EAE-dependent damage by decreasing BBB and BSCB permeability. These results provide rationale for the development of selective inhibitors of Rho kinase as a novel therapy for MS.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21978848     DOI: 10.1016/j.jneuroim.2011.08.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.

Authors:  Yuqing Yan; Jiezhong Yu; Ye Gao; Gajendra Kumar; Minfang Guo; Yijin Zhao; Qingli Fang; Huiyu Zhang; Jingwen Yu; Yuqiang Jiang; Han-Ting Zhang; Cun-Gen Ma
Journal:  Metab Brain Dis       Date:  2018-12-14       Impact factor: 3.584

2.  Increased activity of Rho kinase contributes to hemoglobin-induced early disruption of the blood-brain barrier in vivo after the occurrence of intracerebral hemorrhage.

Authors:  Zhenghao Fu; Yizhao Chen; Fengzhen Qin; Shuo Yang; Xinqing Deng; Rui Ding; Liang Feng; Weiguang Li; Jianfeng Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitis.

Authors:  Yong-Fei Zhao; Xiang Zhang; Zhi-Bin Ding; Xing-Wang Yang; Hui Zhang; Jie-Zhong Yu; Yan-Hua Li; Chun-Yun Liu; Qing Zhang; Hong-Zhen Zhang; Cun-Gen Ma; Bao-Guo Xiao
Journal:  J Mol Neurosci       Date:  2014-09-16       Impact factor: 3.444

4.  Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.

Authors:  Chunyun Liu; Yanhua Li; Jiezhong Yu; Ling Feng; Shaowei Hou; Yueting Liu; Mingfang Guo; Yong Xie; Jian Meng; Haifei Zhang; Baoguo Xiao; Cungen Ma
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

5.  Matrine Treatment Blocks NogoA-Induced Neural Inhibitory Signaling Pathway in Ongoing Experimental Autoimmune Encephalomyelitis.

Authors:  Quan-Cheng Kan; Hui-Jun Zhang; Yuan Zhang; Xing Li; Yu-Ming Xu; Rodolfo Thome; Ming-Liang Zhang; Nan Liu; Yao-Juan Chu; Guang-Xian Zhang; Lin Zhu
Journal:  Mol Neurobiol       Date:  2016-12-09       Impact factor: 5.682

Review 6.  Neurovascular unit in chronic pain.

Authors:  Beatrice Mihaela Radu; Placido Bramanti; Francesco Osculati; Maria-Luisa Flonta; Mihai Radu; Giuseppe Bertini; Paolo Francesco Fabene
Journal:  Mediators Inflamm       Date:  2013-06-05       Impact factor: 4.711

7.  Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.

Authors:  Su Zhang; Quan-Cheng Kan; Yuming Xu; Guang-Xian Zhang; Lin Zhu
Journal:  Mediators Inflamm       Date:  2013-09-08       Impact factor: 4.711

8.  Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.

Authors:  Tomasz Rusielewicz; Jennifer Nam; Evangelos Damanakis; Gareth R John; Cedric S Raine; Carmen V Melendez-Vasquez
Journal:  Glia       Date:  2014-01-28       Impact factor: 7.452

Review 9.  Non-muscle myosin II in disease: mechanisms and therapeutic opportunities.

Authors:  Karen A Newell-Litwa; Rick Horwitz; Marcelo L Lamers
Journal:  Dis Model Mech       Date:  2015-11-05       Impact factor: 5.758

10.  FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.

Authors:  Yan-Le Xin; Jie-Zhong Yu; Xin-Wang Yang; Chun-Yun Liu; Yan-Hua Li; Ling Feng; Zhi Chai; Wan-Fang Yang; Qing Wang; Wei-Jia Jiang; Guang-Xian Zhang; Bao-Guo Xiao; Cun-Gen Ma
Journal:  Biosci Rep       Date:  2015-07-29       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.